Get started
UNITEDHEALTHDRNUNITEDHEALTHDRNUNITEDHEALTHDRN

UNITEDHEALTHDRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

UNHH34 trade ideas

UNH Weekly Trade Summary — Bearish Setup into June 6 Expiry📉 UNH Weekly Trade Summary — Bearish Setup into June 6 Expiry 📊 AI Model Snapshot Model Bias Strike Direction Premium PT / SL Confidence Grok Moderately Bullish $317.5 CALL $0.71 +50% / −20% 65% Claude Moderately Bullish $305 CALL $3.15 +100–150% / −40% 72% Llama Moderately Bearish $287.5 PUT $0.80 +50% / −50% 70% Gemini Moderately Bearish $290 PUT $0.95 +50% / −50% 65% DeepSeek Moderately Bearish $287.5 PUT $0.80 +50% / −50% 65% ✅ Consensus Summary 🟥 3 of 5 models lean bearish based on price below EMAs, weak MACD, and bearish news. 🧲 Max Pain at $305 could cause a bounce but unlikely to reverse trend. 📰 Piper Sandler’s target cut adds downside weight. 💡 Recommended Trade 🔻 Strategy: Weekly Naked Put Play 📌 Ticker: UNH 🎯 Strike: $287.50 PUT 💵 Entry Price: $0.80 🎯 Profit Target: $1.20 (+50%) 🛑 Stop Loss: $0.40 (−50%) 📏 Size: 1 contract 📅 Expiry: 2025-06-06 ⏰ Entry Timing: Market Open 📈 Confidence: 65% ⚠️ Risks to Monitor 🔄 Short-covering bounce could push UNH toward $305 and reduce put premiums fast. ⏳ Time decay (theta) speeds up mid-week — early action preferred. 🔍 Support zone around $300 – if it holds, consider cutting early. 📉 Broad market relief rally could neutralize this bearish edge.
NYSE:UNHShort
by quantsignals
1
UNH : Are Bad Days Over ? (Cautious)UNH shares have moved above the 50-period moving average but are trading below the 200-period moving average. For now, since the 200-period moving average is very high, a small trade can be tried by keeping the stop-loss level a little tight. A few weak movements may pull the average down and the price may break the average. Therefore, small position sizes are ideal. NOTE : If we can maintain persistence on 376(Which will take a few days), then we will look at the other gaps. Risk/Reward Ratio : 2.39 Stop-Loss : 274.99 Take- Profit Level : 376.38 Regards.
NYSE:UNHLong
by Noldo
Panic Creates Opportunity!- Corruption allegations and incidents like assassination have severely damaged the company. However, insider buying activity and a dramatic drop in valuation multiples create an exceptional opportunity. - The absence of issues in profitability or operational performance further reinforces this rare opportunity. - Negative analyst revisions have introduced political pressure on the company, which may persist. - Yet, those who invest when others are fearful often come out ahead. - The stock should be considered for swing trading. The price target aligns with two overlapping levels: the 61.8% retracement of the A-B-C correction wave, and the 261.8% projection of a post-correction 1-2-3-4-5 impulse wave (assuming wave 1 peak is fixed and wave 2 bottom is at the 61.8% level).
NYSE:UNHLong
by Tolgaun6
UNH LONGOh man, what a chart to dig into. (Read the fundamental analysis for this one—I don’t look into company financials or earnings. I’m also not following the news, so that’s on you. I’ve seen too many setups fail because of some unexpected headline or a random tweet on a f***ing Monday from the orange man.) Why am I looking at this setup? We’re sitting right at the 0.618 fib in a bullish trend. That lines up with the POC of a B-shaped volume profile, right at a support level. On top of that, liquidity under the trendline on the left has already been swept, and price is way overstretched from VWAP. So even if this isn’t a full reversal, we should at least get a pullback back toward the VWAP midline. entries at 301 283 264 SL at 236 TP 50% at 492, and let the rest rides There’s a lot going on here: Trend direction is still up. As long as we don’t get a close below 187, this is just a pullback. VWAP is miles away from the current price. Price doesn’t stay that far from it forever—it either pulls back or consolidates before heading higher. Fibs and TLs: There’s a major trendline (marked as Area 2) that hasn’t been touched for the third time yet. That same zone lines up with the 0.78 fib. Price hasn’t reached it yet—might not—but that’s still a spot I’d seriously consider for a long. POC zone: The marked long area is right on the POC of a B-profile. It’s a key level and should act as support. That’s a solid place to look for a bounce. I’ve marked out the setup and three possible entries. These are the spots I’d look to long from. If they all fail, then Area 2 is the backup—it should hold. One more thing: there’s a red line in the middle of the chart. If you want more confirmation, wait for price to close above it, then catch the retrace. That gives you more confidence in the setup. Do your own analysis and keep an eye on the news. TA only works if it lines up with the fundamentals. If not, it’s useless.
NYSE:UNHLong
by lojjkkjvvv
UNH: Why I Believe This Is a Dead Cat Bounce(Late posting)We’ve seen a quite the abounce in the market as of lately, but I believe it’s not a real recovery. To me, this looks like a classic dead cat bounce; a quick move up that happens during a downtrend before prices drop again. I’ll explain why I think this is the case, kind of a simple one. First of all, the grand picture in the economy still looks fairly negative, especially respecting the TRUMP TARIFF new. Inflation hasn’t fully gone away, interest rates are still high, and consumer confidence is weak. There’s no major change in the news or the fundamentals that would support a strong comeback. It feels like people are just hoping things will improve, but the facts don’t really support that yet. Second, the volume on this bounce has been low. In trading, volume tells you how strong a move is. If the price goes up but not many people are trading, it usually means there’s not much real buying happening. This bounce seems to be driven more by short sellers covering their positions, not by confident investors jumping in. Third, we’re hitting key resistance levels—areas where the price dropped before—and we’re starting to see signs of rejection again. These levels are often hard to break through unless the market has strong momentum, and right now it doesn’t look like that’s the case. Fourth, if you look at indicators like the RSI and MACD, they show that the price is already overbought. That means the recent move up may have gone too far, too fast. These kinds of readings usually lead to a pullback, especially when the bigger trend is still down. Finally, the overall structure of the chart hasn’t changed. We’re still making lower highs and lower lows, which is what a downtrend looks like. Just because we’ve had a few green candles doesn’t mean the trend has reversed. Until we see the market start building a base and making new highs with strong support, I don’t think this bounce will last. I n my opinion, this is one of those moments where people might get too excited too quickly. A lot of traders jump in thinking the bottom is in, only to get caught when the price turns back down. That’s why I’m staying cautious and watching for signs that the bounce is failing. I could be wrong, but right now, this feels more like a trap than a turning point.
NYSE:UNHShort
by ThePlotThickens
7
UNH Long Setup – Oversold Reversal PlayUnitedHealth ( NYSE:UNH ) is showing early signs of a potential bounce after a brutal selloff. 🔹 Price broke above the baseline (Ichimoku), first green candle close with bullish momentum 🔹 Williams %R showing oversold bounce from -80 levels 🔹 MACD turning positive on multiple timeframes 🔹 Clean risk/reward setup: ‣ Entry: $293 ‣ Target: $455 (55% upside) ‣ Stop: $249 (15% risk) ‣ R/R Ratio: 3.5+ This could be a high-reward reversal play if market strength continues. Watching closely for follow-through confirmation. #UNH #stocks #longsetup #tradingview #healthcare #swingtrade #technicalanalysis #chartsetup #Ichimoku
NYSE:UNHLong
by aaronkaltman
4
UNH Weekly Options Outlook — June 1, 2025📉 UNH Weekly Options Outlook — June 1, 2025 🚨 AI Model Consensus: Bearish Bias with Relief Rally Risks 🧠 Model Insights 🔹 Claude (Anthropic) Bias: Moderately Bullish Technical: Daily MACD turning up, RSI recovering; short-term neutral-bullish. Trade: Buy $305C @ ~$4.95 → PT +50–60%, SL ~30% Confidence: 65% 🔹 Llama (Meta) Bias: Moderately Bearish Technical: M5 bullish, daily bearish; Bollinger/MACD mixed. Trade: Buy $280P @ $0.94 → PT +50%, SL = $0.20 or if UNH > $307 Confidence: 70% 🔹 DeepSeek Bias: Moderately Bearish Technical: M5 squeeze; daily bearish but showing bullish divergence. Trade: Buy $300P @ $5.70 → PT $8.55 (+50%), SL $3.99 (−30%) Confidence: 65% 🔹 Gemini (Google) Bias: Moderately Bullish Technical: Oversold daily with bounce signals; bullish 5M EMAs. Trade: Buy $320C @ ~$1.45 → PT $2.75–2.90, SL $0.72 Confidence: 65% 🔹 Grok (xAI) Bias: Moderately Bearish Trade: Buy $280P @ $0.94 → PT +15%, SL −50% Confidence: 70% ✅ Consensus Takeaways ⚖️ Short-term EMAs bullish, daily trend still bearish 🧲 Max Pain @ $300 = key anchor zone 📰 Negative news priced in, VIX falling 🔻 3 of 5 models lean bearish, but short-term bounce is possible 🎯 Recommended Trade 💡 Strategy: Naked Weekly Put on UNH 🔘 Ticker: UNH 📉 Direction: PUT 🎯 Strike: $300 💵 Entry: $6.00 🎯 Profit Target: $9.00 (+50%) 🛑 Stop Loss: $4.20 (−30%) 📏 Size: 1 contract 📅 Expiry: 2025-06-06 ⏰ Entry Timing: Market Open 📈 Confidence: 60% ⚠️ Key Risks to Monitor 🔼 Short-term RSI/MACD bounce could squeeze puts 🧲 Max Pain $300 could magnet price sideways ⌛ Theta decay accelerates midweek—trade must move early ⚡ Watch VIX—any spike could rapidly change momentum 📊 TRADE DETAILS (JSON) json Copy Edit { "instrument": "UNH", "direction": "put", "strike": 300.0, "expiry": "2025-06-06", "confidence": 0.60, "profit_target": 9.00, "stop_loss": 4.20, "size": 1, "entry_price": 6.00, "entry_timing": "open", "signal_publish_time": "2025-06-01 00:11:01 UTC-04:00" }
NYSE:UNHShort
by quantsignals
$UNH contrarian idea ..Hello, this seems to be the "BUY THE DIP!" name definitely on the retail side. A guy once told me, if everyone is talking about getting into something, buying something, it might be a good time to sell and get out of that something. Example: I have been buying Bitcoin for five years, the price has risen and now everybody is talking about Bitcoin, that might be a clear indicator to sell some of that position and take profits; contrarian. So, something is telling me this name isn't ready to just ride to the upside like everybody is imagining. A big zone is down around $200, a 7 year demand. This name is in turmoil, randomness happens. I believe the name would have kept going down if the insider buy did not come in and bring some momentum. I can see this name retracing back to $275 and below. Will be interesting to see. On watch is $275p 6/20. WSL
NYSE:UNHShort
by wallstreetloser001
$UNH still looks very uglyI'm still bearish on NYSE:UNH until 335-340 area gets taken out. The chart is so ugly. We've seen many "too big to fail" companies die out eventually. Will NYSE:UNH survive all this bad publicity? Insider action, options flow suggest this isn't going "parabolic" anytime soon lol sorry bulls The technicals just don't align YET to the upside. This is still so far from major moving averages on the higher time frames... the volume dried out after those huge moves and consumers hate them right now lol.. this is feeling like NYSE:GME apes versus wall street bullies. Except its NYSE:UNH versus the insured consumers finance.yahoo.com 20EMA on the daily = 342 still not even close Also FYI - NYSE:UNH is not the type of stock that goes parabolic, nothing sexy on the options flow either Below 290, I've got 275, 260, and 210 gap down. Good luck bulls and bears
NYSE:UNHShort
by chrisgxtct6663
UNH Under Pressure – Below EMA 200 with Heavy Selling VolumeUNH (UnitedHealth) is showing clear bearish signs: Price has dropped below the EMA 200, a key long-term support level Recent sessions show strong selling volume, indicating institutional exit Trend is downward, with no bullish confirmation yet ⚠️ I stay cautious here — waiting for volume shift or price reclaim above EMA before considering a reversal. Until then, the bearish momentum stays active. Not financial advice – just my technical view. #UNH #StockAnalysis #BearishTrend #VolumeAnalysis #EMA200 #TechnicalTrading #HealthcareStocks
NYSE:UNH
by abdeljalillariam
Near-Term Rebound or Continued Weakness Ahead? Targets: - T1 = $301.50 - T2 = $308.00 Stop Levels: - S1 = $287.50 - S2 = $283.00 **Wisdom of Professional Traders:** This analysis synthesizes insights from thousands of professional traders and market experts, leveraging collective intelligence to identify high-probability trade setups. The wisdom of crowds principle suggests that aggregated market perspectives from experienced professionals often outperform individual forecasts, reducing cognitive biases and highlighting consensus opportunities in UnitedHealth Group. **Key Insights:** UnitedHealth Group (UNH) finds itself at a technical and strategic inflection point, presenting opportunities for near-term positioning. This healthcare giant has struggled with recent sector-wide headwinds, including concerns around reimbursement rates and broader market volatility. The $295 level represents a significant area of consolidation, with resistance looming around $300-$308. Analysts emphasize close monitoring of volume spikes as they could signal either bullish conviction or continuation of recent weakness. A deeper dive into sector fundamentals indicates that defensive healthcare stocks may benefit from a potential market rotation, particularly if the broader market encounters volatility. UnitedHealth Group's dominating position within managed healthcare leaves it well-positioned long-term, but short-term sentiment has weighed heavily, leading to over 10% declines in the last month. **Recent Performance:** Shares of UNH have declined in tandem with broader healthcare indices, lagging behind key benchmark ETFs like XLV. Over the last month, the stock dropped sharply from the $330 range and now faces strong technical resistance near $300. Recent market weakness reflects unfavorable investor sentiment as well as concerns over federal investigations and leadership uncertainty. Expert Analysis: From a technical perspective, traders point to the $287-$290 range as a critical support zone. A bounce off these levels could lead to short-term retracement opportunities targeting $301 and $308. Below $287, the stock could face further downside to the $275 level. Expert traders recommend cautious LONG positions, highlighting the importance of clearly defined stop-loss orders to navigate the current turbulent environment. Sentiment remains mixed due to ongoing investigations into Medicare billing practices. News Impact: Recent headlines around a federal probe into UnitedHealth’s Medicare business and the resignation of its CEO have created a cloud of uncertainty around the stock. This type of news-driven sentiment has weighed heavily on the share price and could limit near-term upside unless key questions around corporate governance and regulatory compliance are addressed. Trading Recommendation: Considering its current technical levels and mixed sentiment, we adopt a cautiously bullish stance on UNH. Traders may consider entering LONG positions near $295 with a stop-loss below $287 to protect initial capital. Upside targets of $301 and $308 are realistic in the short term, but disciplined risk management is critical given heightened volatility within the healthcare sector.
NYSE:UNHLong
by CrowdWisdomTrading
UnitedHealth Group:A Healthcare Giant Undervalued Amid AI GrowthUnitedHealth Group NYSE:UNH , the largest health insurer in the U.S., has faced turbulence, with its stock dropping from $600 to $295.57-a 53.1% decline since its peak. Despite challenges, UNH presents a compelling value play, leveraging AI to drive growth and efficiency. Here’s why investors should consider this healthcare titan at its current price. A Rough Road: DOJ Probe and Public Backlash UNH’s recent struggles stem from two major events. In December 2024, Brian Thompson, CEO of its insurance division, passed away in New York City, sparking criticism of UNH and the U.S. health insurance system. Following this, the U.S. Department of Justice launched an investigation in early 2025, alleging potential Medicare fraud through inflated treatment costs in UNH’s Medicare Advantage business. These events have shaved over $225 billion off UNH’s market cap since November 2024, bringing it to $264.80 billion. However, such challenges are not something new for large corporations. Historically, giants like UNH settle regulatory issues with fines rather than severe penalties. Warren Buffett’s Berkshire Hathaway NYSE:BRK.A remains a major shareholder, signaling confidence in UNH’s governance and long-term stability. Financial Strength and Undervaluation Despite the selloff, UNH’s fundamentals remain robust. The stock trades at a P/E ratio of 11.4x, down from 17 earlier in May 2025, reflecting the price drop. Analysts project 2025 EPS at $30, implying a forward P/E of 9.7-a bargain for a company of UNH’s stature. Its 3.1% dividend yield, bolstered by 15 years of consecutive increases, adds income appeal. With a market-leading position, serving ~150 million individuals globally, and strong cash flows, UNH is well-positioned to weather short-term storms. AI: A Catalyst for Growth UNH is harnessing AI to transform its operations. Handling ~5 billion claims annually, the company uses AI to automate claims processing, reducing costs and boosting margins. AI also analyzes patient data to assist doctors with treatment decisions, enhancing care quality. Beyond internal efficiency, UNH aims to monetize this technology by selling AI solutions to other insurers and medical institutions, opening a new revenue stream. Such moves and steps in this way aligns with UNH’s broader strategy of leveraging technology to modernize healthcare, as seen in its Optum division’s focus on data analytics and pharmacy services. Investment Case: Buy on Weakness? At $295.57, UNH is undervalued, offering a margin of safety for long-term investors. Its forward P/E of 9.7 and 3.1% dividend yield make it attractive, while AI-driven growth positions it for future gains. Risks remain, as usual-regulatory fines and market volatility could pressure the stock-but healthcare’s resilience and UNH’s leadership mitigate these concerns. Investors seeking a stable, growth-oriented play in a turbulent market may find UNH as a pretty well buy case.
NYSE:UNHLong
by juliakhandoshko
UNH watch $288-297: Double Golden zone a serious Long Term Buy?UNH keeps getting bad news but may have bottomed. Wave may have tested Double Golden fibs successfully. Looking for some consolidation then launch of recovery. $287.91-296.92 (Gold) is the key zone of interest. $382.05-384.18 (Red) is the first long term target. $251.94-255.83 (Green) is the MUST_HOLD bottom. . Previous Analysis that caught the top EXACTLY Follow and Boost to encourage more such PRECISE charts. ================================================== .
NYSE:UNH
by EuroMotif
4